JCO issue on supportive and palliative cancer care

Benefited from the US Food and Drug Administration to allow for metastatic breast cancer for the first molecular test, surgical experts can more quickly assess whether there is a proliferation of breast cancer risk.
Herceptin in combination with paclitaxel is indicated for treatment of HER2-positive metastatic breast cancer. Herceptin as a single agent is indicated for treatment of HER2-positive breast cancer in patients who have received one or
We have examined data from a prospective cohort study looking at patient and family needs among women with hormone-refractory metastatic breast cancer treated at two Canadian regional cancer centers, and limited analysis to the patients
The safety and effectiveness of chemoembolization for breast cancer metastases is unknown as only case reports and series have so far been reported. The largest series reported in a 2008 abstract was of 217 pateints but this as not a
The safety and effectiveness of chemoembolization for breast cancer metastases is unknown as only case reports and series have so far been reported. The largest series reported in a 2008 abstract was of 217 pateints but this as not a